Literature DB >> 15028673

A potential role for the nucleolus in L1 retrotransposition.

John L Goodier1, Eric M Ostertag, Kurt A Engleka, Maria C Seleme, Haig H Kazazian.   

Abstract

Determining the subcellular localization of the L1 ORF2 protein (ORF2p) has been impossible to date because of technical limitations in detecting either endogenous or overexpressed forms of the protein. Here we report visualization of the full-length ORF2p in cultured human cells following expression in a modified vaccinia virus/T7 RNA polymerase (MVA/T7RP) system. The MVA/T7RP system was used to ascertain subcellular localization of L1 ORF1p and ORF2p both as fusions with green fluorescent protein and by immunocytochemistry. Full-length ORF2p was predominantly cytoplasmic, while carboxy-terminal-deleted ORF2p localized additionally to the nucleolus. We mapped a functional nucleolar localization signal in ORF2p. ORF1p appeared in the cytoplasm with a speckled pattern and colocalized with ORF2p in nucleoli in a subset of cells. These findings help explain the presence of chimeras between L1s and small RNA gene sequences recently discovered in the human genome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028673     DOI: 10.1093/hmg/ddh118

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  63 in total

1.  Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility.

Authors:  Silke Wissing; Martin Muñoz-Lopez; Angela Macia; Zhiyuan Yang; Mauricio Montano; William Collins; Jose Luis Garcia-Perez; John V Moran; Warner C Greene
Journal:  Hum Mol Genet       Date:  2011-10-11       Impact factor: 6.150

2.  Intact piRNA pathway prevents L1 mobilization in male meiosis.

Authors:  Simon J Newkirk; Suman Lee; Fiorella C Grandi; Valeriya Gaysinskaya; James M Rosser; Nicole Vanden Berg; Cathryn A Hogarth; Maria C N Marchetto; Alysson R Muotri; Michael D Griswold; Ping Ye; Alex Bortvin; Fred H Gage; Jef D Boeke; Wenfeng An
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

3.  Multiple fates of L1 retrotransposition intermediates in cultured human cells.

Authors:  Nicolas Gilbert; Sheila Lutz; Tammy A Morrish; John V Moran
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  Essential domains for ribonucleoprotein complex formation required for retrotransposition of telomere-specific non-long terminal repeat retrotransposon SART1.

Authors:  Takumi Matsumoto; Mitsuhiro Hamada; Mizuko Osanai; Haruhiko Fujiwara
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  L1 retrotransposition in nondividing and primary human somatic cells.

Authors:  Shuji Kubo; Maria Del Carmen Seleme; Harris S Soifer; José Luis Garcia Perez; John V Moran; Haig H Kazazian; Noriyuki Kasahara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-12       Impact factor: 11.205

6.  Enrichment of processed pseudogene transcripts in L1-ribonucleoprotein particles.

Authors:  Prabhat K Mandal; Adam D Ewing; Dustin C Hancks; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2013-05-21       Impact factor: 6.150

7.  Unconventional translation of mammalian LINE-1 retrotransposons.

Authors:  Reid S Alisch; Jose L Garcia-Perez; Alysson R Muotri; Fred H Gage; John V Moran
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

8.  L1 mobile element expression causes multiple types of toxicity.

Authors:  Nicholas A Wallace; Victoria P Belancio; Prescott L Deininger
Journal:  Gene       Date:  2008-05-03       Impact factor: 3.688

9.  Characterization of LINE-1 ribonucleoprotein particles.

Authors:  Aurélien J Doucet; Amy E Hulme; Elodie Sahinovic; Deanna A Kulpa; John B Moldovan; Huira C Kopera; Jyoti N Athanikar; Manel Hasnaoui; Alain Bucheton; John V Moran; Nicolas Gilbert
Journal:  PLoS Genet       Date:  2010-10-07       Impact factor: 5.917

10.  The RNA polymerase dictates ORF1 requirement and timing of LINE and SINE retrotransposition.

Authors:  Emily N Kroutter; Victoria P Belancio; Bradley J Wagstaff; Astrid M Roy-Engel
Journal:  PLoS Genet       Date:  2009-04-24       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.